Podiatrists in Dawsonville, GA Accepting Medicare

4 Podiatrists found. Showing 1 - 4

Gruen Podiatry Podiatrist Medicare: Medicare Enrolled Practice Location: 400 Dawson Commons Cir Ste 420, Dawsonville, GA 30534 Phone: 706-216-8637    Fax: 706-815-5509

Ankle & Foot Centers Of North Georgia Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 133 Prominence Court, Suite 210, Dawsonville, GA 30534 Phone: 706-265-6600    Fax: 706-265-6604

Dr. Eric John Kron, D.P.M., F.A.C.F.A.S. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 81 Northside Dawson Dr Ste 204, Dawsonville, GA 30534 Phone: 706-265-6600    Fax: 706-265-6604

Dr. Eric D Gruen, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 400 Dawson Commons Cir Ste 420, Dawsonville, GA 30534 Phone: 706-216-8637    Fax: 815-550-9967

News Archive

Strong free-electron lasers can be used to break down amyloid protein aggregates

Amyloid fibrils are a type of self-assembled proteins/peptides that take on a stacked sheet-like formation. Amyloid fibril aggregates are known to be a cause of several diseases-including Alzheimer's-and therefore, it is of immense scientific interest to understand how these aggregates can be broken.

AGS publishes policy brief to address COVID-19 concerns in assisted living facilities

In a policy brief published today in its namesake journal, the American Geriatrics Society (AGS) offered a roadmap to guide federal, state, and local governments addressing COVID-19 concerns in an important but oft-overlooked arena: Assisted living facilities (ALFs).

Sugar-attaching enzyme found to be abundant in colon cancer cells

Researchers have identified an enzyme that is absent in healthy colon tissue but abundant in colon cancer cells, according to a report in the Jan. 26 issue of the Journal of Biological Chemistry.

Chimerix initiates enrollment in CMX001 clinical study for life-threatening conditions caused by dsDNA viruses

Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced that patient enrollment has begun in a multicenter, open-label clinical study of CMX001 (the CMX001-350 study) for the treatment of life-threatening or serious conditions caused by double-stranded DNA (dsDNA) viruses.

Read more Medical News

› Verified 9 days ago